Defining Health Care’s Future: Digital Health, Innovation Accessible, Prevention Importance as Cure | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Feeds:: Posts; Comments

« Skin Regeneration Therapy One of First Tissue Engineering Products Evaluated by FDA

36th Annual J.P. Morgan HEALTHCARE CONFERENCE January 8 – 11, 2018 »

Defining Health Care’s Future: Digital Health, Innovation Accessible, Prevention Importance as Cure

January 9, 2018 by 2012pharmaceutical

Defining Health Care’s Future: Digital Health, Innovation Accessible, Prevention Importance as Cure – The Vision of Stanford Medical School Dean delivered at 2018 JP Morgan in San Francisco

Reporter: Aviva Lev-Ari, PhD, RN

At JPM 2018: Three Challenges That Will Define Health Care’s Future

Published on Published on January 8, 2018

Lloyd Minor, LinkedIn Influencer

Carl and Elizabeth Naumann Dean, Stanford University School of Medicine

https://www.linkedin.com/pulse/jpm-2018-three-challenges-define-health-cares-future-lloyd-minor/?trackingId=e9O96U%2FFW9LDGKaIw%2Bt8xw%3D%3D

Posted in Digital HealthCare – biotech & internet joint ventures, Healthcare costs and reimbursement, HealthCare IT, Interviews with Scientific Leaders, United States | Leave a Comment

Leave a ReplyCancel reply

Follow Blog via Email

Enter your email address to follow this blog and receive notifications of new posts by email.

Email Address

Join 9,319 other subscribers
Recent Posts
Archives
Archives
Categories
Categories
Meta

%d bloggers like this: